Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BG Medicine, Inc. (NQ: BGMD)
1.720 USD  -0.070 (-3.91%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about BG Medicine, Inc.
 
< Previous 1 2 3 Next >
Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
May 22, 2013
from PR Newswire
BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
May 10, 2013
from GlobeNewswire News Releases
BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer
May 09, 2013
from GlobeNewswire News Releases
BG Medicine Reports 2013 First Quarter Financial Results
May 09, 2013
from GlobeNewswire News Releases
Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions
May 08, 2013
from GlobeNewswire News Releases
BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013
May 02, 2013
from GlobeNewswire News Releases
Syros Pharmaceuticals Launches with $30 Million Series A Financing
April 11, 2013
from Business Wire News Releases
BG Medicine Welcomes CE Mark for Galectin-3 Test
April 10, 2013
from GlobeNewswire News Releases
Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patients
April 10, 2013
Galectin-3 test may help physicians identify patients at highest risk for a worse prognosis, including re-hospitalization and death, allowing them to tailor the level of care to individual patient... Read More
from PR Newswire
Free Research Reports on BGMD, BIOF, GEVO and MLNX Issued by the Bedford Report
April 08, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
BG Medicine Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 Outlook
March 13, 2013
Fourth Quarter and Full Year BGM Galectin-3 Test Sales Grow Significantly Read More
from GlobeNewswire News Releases
BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013
March 06, 2013
from GlobeNewswire News Releases
BG Medicine Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's (ACC) 62nd Annual Scientific Session & Expo
March 06, 2013
from GlobeNewswire News Releases
BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients
February 27, 2013
from GlobeNewswire News Releases
BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
February 27, 2013
from GlobeNewswire News Releases
Free Research Report on Brunswick Corp., BG Medicine, Inc., BioScrip, Inc., Bloomin' Brands, Inc. and Blount International, Inc.
January 31, 2013
from PR Newswire
BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option
January 30, 2013
from GlobeNewswire News Releases
Free Research Reports on BGMD, MCP, RSH and THLD Issued by the Bedford Report
January 28, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
BG Medicine, Inc. Prices $12.0 Million Public Offering of Common Stock
January 25, 2013
from GlobeNewswire News Releases
BG Medicine, Inc. Enters Into $12 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
January 24, 2013
from GlobeNewswire News Releases
BG Medicine, Inc. Announces Proposed Public Offering of Common Stock
January 24, 2013
from GlobeNewswire News Releases
Biotech Industry Expected to Experience More M&A Activity in 2013
January 21, 2013
Five Star Equities Provides Stock Research on BG Medicine and YM BioSciences Read More
from Marketwired News Releases
The Real Story Behind ZAGG, CLSN, YELP and BGMD
January 08, 2013
from Marketwired News Releases
Free Research Reports on BGMD, FOLD, PPHM and TSL Issued by the Bedford Report
January 04, 2013
The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test
January 02, 2013
First Automated Test Launches in Europe and Territories Recognizing the CE Mark Read More
from GlobeNewswire News Releases
The Real Story Behind ALLT, ELGX, ACAD and BGMD
December 14, 2012
from Marketwired News Releases
Top Stock Movers: Molycorp, Inc. (NYSE: MCP), BG Medicine, Inc. (NASDAQ: BGMD), Acura Pharmaceuticals Inc. (NASDAQ: ACUR), Psychic Friends Network Inc. (OTCQB: PFNI)
December 12, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012
December 12, 2012
Five Star Equities Provides Stock Research on BG Medicine and Cardiome Pharma Read More
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: ACUR, SOMX, BGMD and DNDN
December 12, 2012
from Marketwired News Releases
Traders and Investors Trend Analysis Reports: (NASDAQ: BGMD), (NASDAQ: SOMX)
December 11, 2012
from SBWire Direct - Latest Press Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here